Anthem Biosciences Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences Limited has filed its financial results with the Exchange for the third quarter and the nine-month period ending December 31, 2025. This is a routine quarterly compliance filing disclosing the company's performance for the period. The detailed financial figures (revenue, profit, margins, segment performance) are contained in the attached results document and were not part of this announcement notice.
The filing itself is a standard regulatory disclosure and typically has no direct price impact on its own. Investors should review the detailed results for revenue growth, profit trends, and margin movement to assess the company's performance versus expectations.